Literature DB >> 2188671

Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection.

B Chesebro1, M Miyazawa, W J Britt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2188671     DOI: 10.1146/annurev.iy.08.040190.002401

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


× No keyword cloud information.
  64 in total

1.  Kinetics of the development of protective immunity in mice vaccinated with a live attenuated retrovirus.

Authors:  U Dittmer; B Race; K J Hasenkrug
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Spontaneous priming for anti-viral envelope cytotoxic T lymphocytes in mice transgenic for a murine leukaemia virus envelope gene (Fv4).

Authors:  A Nihrane; J Silver
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

3.  Mutations in the env gene of friend spleen focus-forming virus overcome Fv-2r-mediated resistance to Friend virus-induced erythroleukemia.

Authors:  M K Majumdar; C L Cho; M T Fox; K L Eckner; S Kozak; D Kabat; R W Geib
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

4.  Elimination of friend retrovirus in the absence of CD8+ T cells.

Authors:  Sachiyo Tsuji-Kawahara; Masaaki Miyazawa
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

Review 5.  Immunity to retroviral infection: the Friend virus model.

Authors:  K J Hasenkrug; B Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

6.  Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness.

Authors:  K J Hasenkrug; D M Brooks; B Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

7.  Contrasting effects from a single major histocompatibility complex class II molecule (H-2E) in recovery from Friend virus leukemia.

Authors:  L L Perry; M Miyazawa; K Hasenkrug; K Wehrly; C S David; B Chesebro
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  Dissecting the immune response to moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach.

Authors:  G Milan; A Zambon; M Cavinato; P Zanovello; A Rosato; D Collavo
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus.

Authors:  Shelly J Robertson; Christoph G Ammann; Ronald J Messer; Aaron B Carmody; Lara Myers; Ulf Dittmer; Savita Nair; Nicole Gerlach; Leonard H Evans; William A Cafruny; Kim J Hasenkrug
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

10.  Suppression of H-2b-associated resistance to Friend erythroleukemia virus by a class I gene from the H-2d major histocompatibility complex haplotype.

Authors:  D Polsky; F Lilly
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.